Nucleic Acid Therapeutics
| Nucleic Acid Therapeutics
|
|
|---|---|
| description | Peer-reviewed journal |
| Area of Expertise | chemistry |
| language | English |
| publishing company | Mary Ann Liebert ( United States of America ) |
| First edition | 1991 |
| Frequency of publication | 6 / year |
| Web link | Website of the magazine |
| ISSN (print) | 2159-3337 |
Nucleic Acid Therapeutics , abbreviated to Nucl. Acid Ther. , is a scientific journal published by Mary Ann Liebert-Verlag. The journal was founded in 1991 under the name Antisense: Research and Development . In 1996 there was a change to Antisense & Nucleic Acid Drug Development , which was followed by a shortening of the title to Oligonucleotides in 2003 . The journal has been called Nucleic Acid Therapeutics since 2011 and appears with six issues a year. It is the official publication of the Oligonucleotide Therapeutics Society . Works are published that deal with the use of nucleic acids as therapeutic agents.
The impact factor in 2014 was 2.929. According to the statistics of the ISI Web of Knowledge , the Journal with this Impact Factor in the category medicinal chemistry at 20th out of 59 journals in the category Biochemistry and Molecular Biology at the 132nd place of 289 magazines and in the category experimental and research-based medicine to 46th place out of 123 magazines.
Individual evidence
- ^ Website of the journal ; accessed on December 31, 2014.
- ↑ 2014 Journal Citation Reports, Science Edition (Thomson Reuters, 2015).